Infectious Optimism following the 10th International Oncolytic Virus Meeting

by Matthew J. Atherton, Laura Evgin, Brian A. Keller, Mira M. Shenouda, Kyle B. Stephenson, Richard G. Vile, John C. Bell, David H. Evans, Brian D. Lichty
Published 2017-12-01

Assessing the Completeness of Reporting in Preclinical Oncolytic Virus Therapy Studies

by Dean A. Fergusson, Neil L. Wesch, Garvin J. Leung, Jenna L. MacNeil, Isidora Conic, Justin Presseau, Kelly D. Cobey, Jean-Simon Diallo, Rebecca Auer, Jonathan Kimmelman, Natasha Kekre, Nader El-Sayes, Ramya Krishnan, Brian A. Keller, Carolina Ilkow, Manoj M. Lalu
Published 2019-09-01

Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies

by Laura Evgin, Carolina S Ilkow, Marie-Claude Bourgeois-Daigneault, Christiano Tanese de Souza, Lawton Stubbert, Michael S Huh, Victoria A Jennings, Monique Marguerie, Sergio A Acuna, Brian A Keller, Charles Lefebvre, Theresa Falls, Fabrice Le Boeuf, Rebecca A Auer, John D Lambris, J Andrea McCart, David F Stojdl, John C Bell
Published 2016-01-01